Benzene and hematopoietic malignancies

Clinics in Occupational and Environmental Medicine

Volumn 4, Issue 3, 2004, Pages 529-555

  Pyatt, David ^a,b  

^a CARDNO CHEMRISK   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; BENZENE; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE TOXICITY; APLASTIC ANEMIA; BONE MARROW TOXICITY; CANCER GROWTH; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC TOXICITY; DRUG INDUCED CANCER; ENVIRONMENTAL EXPOSURE; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMOGENESIS; METASTASIS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; OCCUPATIONAL EXPOSURE; REVIEW; TOXICOKINETICS;

BENZENE; ENVIRONMENTAL EXPOSURE; HUMANS; LEUKEMIA; LYMPHOMA; OCCUPATIONAL EXPOSURE;

EID: 4444302315     PISSN: 15260046     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coem.2004.03.014     Document Type: Review

References (198)

1. Hunter D. Diseases of occupations 1975 471 English Universities Press London
2. Hamilton A. Benzene (benzol) poisoning: general review Arch Pathol Lab Med 11 1931 434-445
3. Browning E. Toxicity and metabolism of industrial solvents 1965 Elsevier London
4. Brief R.S. Lynch J. Bernath T. Scala R.A. Benzene in the workplace Am Ind Hyg Assoc J 41 1980 616-623
5. Bowditch M. Elkins H.B. Chronic exposure to benzene (benzol) I. The industrial aspects Journal of Industrial Hygiene and Toxicology 21 1939 321-331
6. Aksoy M. Erdem S. Follow-up study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene Blood 52 2 1978 285-292
7. Wallace L. Environmental exposure to benzene: an update Environ Health Perspect 104 Suppl 6 1996 1129-1136
8. Runion H.E. Benzene in gasoline Am Ind Hyg Assoc J 36 1975 338-350
9. Isbell M. Ricker J. Gordian M.E. Duffy L.K. Use of biomarkers in an indoor air study: lack of correlation between aromatic VOCs with respective urinary biomarkers Science of the Total Environment 241 1-3 1999 151-159
10. Moolenaar R.L. Hefflin B.J. Ashley D.L. Middaugh J.P. Etzel R.A. Blood benzene concentrations in workers exposed to oxygenated fuel in Fairbanks, AK Int Arch Occup Environ Health 69 1997 139-143
11. Environmental Protection Agency The total exposure assessment methodology (TEAM) study: summary and analysis 1987 Environmental Protection Agency Washington, DC
12. Wallace L.A. Pellizzari E.D. Personal air exposures and breath concentrations of benzene and other volatile hydrocarbons for smokers and nonsmokers Toxicol Lett 35 1986 113-116
13. Wallace L.A. Major sources of benzene exposure Environ Health Perspect 82 1989 165-169
14. Srbova J. Teisinger J. Kramovsky S. Absorption and elimination of inhaled benzene in man A M A Arch Ind Hyg Occup Med 2 1950 1-8
15. Greenlee W.F. Gross E.A. Irons R.D. Benzene disposition in the rat after exposure by inhalation Toxicol Appl Pharmacol 49 1979 417-423
16. Irons R.D. Dent J.G. Edgar T.S. Rickert D.E. Relationship between benzene toxicity and the deposition of 14C-labeled benzene metabolites in the rat Chem Biol Interact 33 1978 285-299
17. Sawahata T. Rickert D.E. Greenlee W.F. Metabolism of benzene and its metabolites in bone marrow In: Irons R.D. (Ed.), Toxicology of blood and bone marrow 1985 141-148 Raven Press New York
18. Harrison K. Randoll F.W. An application of bone marrow cultures to toxicology and therapeutics J Exp Physiol 34 1947 141-152
19. Andrews L.S. Lee E.W. Witmer C.M. Kocsis J.J. Snyder R.S. Effects of toluene on the metabolism, disposition and hematopoietic toxicity of benzene Biochem Pharmacol 26 1977 293-300
20. Plappert U. Barthel E. Seidel H.J. Reduction of benzene toxicity by toluene Environ Mol Mutagen 24 1994 283-292
21. Sammett D. Lee E.W. Kocsis J.J. Snyder R. Partial hepatectomy reduced both metabolism and toxicity of benzene J Toxicol Environ Health 5 1979 785-792
22. Gill D.P. Kempen R.R. Nash J.B. Ellis S. Modifications of benzene myelotoxicity and metabolism by phenobarbital, SKF-525A and 3-methylcholanthrene Life Sci 25 1979 1633-1640
23. Gad-El-Karim M.M. Ramanujam V.M.S. Ahmed A.E. Legator M.S. Benzene myeloclastogenicity: a function of its metabolism Am J Ind Med 7 1985 475-484
24. Valentine J.L. Lee S.S.T. Seaton M.J. Asgharian B. Farris G. Corton J.C. et al. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression Toxicol Appl Pharmacol 141 1996 205-213
25. Parke D.V. Williams R.T. Studies in detoxication: the metabolism of benzene. (a) The determination of phenylmercapturic acid in urine. (b) Mercapturic acid excretion by rabbits receiving benzene Biochem J 48 1951 624-629
26. 1]benzene Biochem J 54 1953 231-238
27. Parke D.V. Williams R.T. Studies in detoxication: the metabolism of benzene. (a) The determination of benzene. (b) The elimination of unchanged benzene by rabbits Biochem J 46 1950 236-243
28. 3H-benzene metabolism in rabbit bone marrow Life Sci 25 1979 567-572
29. Ross D. Siegel D. Schattenberg D.G. Sun X.M.M. Moran J.L. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity Environ Health Perspect 104 Suppl 6 1996 1177-1182
30. Schlosser M.J. Kalf G.F. Metabolic activation of hydroquinone by macrophage peroxidase Chem Biol Interact 72 1989 191-207
31. Smith M.T. Yager J.W. Steinmetz K.L. Eastmond D.A. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity Environ Health Perspect 82 1989 23-29
32. Genter M.B. Recio L. Absence of detectable P450 2E1 in bone marrow of B6C3F1 mice: relevance to butadiene-induced bone marrow toxicity Fundam Appl Toxicol 22 1994 469-473
33. Snyder R.S. Lee E.W. Kocsis J.J. Binding of labeled benzene metabolites to mouse liver and bone marrow Res Commun Chem Pathol Pharmacol 20 1 1978 191-194
34. Ross D. The role of metabolism and specific metabolites in benzene induced toxicity: evidence and issues J Toxicol Environ Health A 61 2000 357-372
35. Snyder R. Hedli C.C. An overview of benzene metabolism Environ Health Perspect 104 Suppl 6 1996 1165-1171
36. Ruppert T. Scherer G. Tricker A.R. Adlkofer F. Trans, trans-muconic acid as a biomarker of non-occupational environmental exposure to benzene Int Arch Occup Environ Health 69 1997 24-251
37. Yu R. Weisel C.P. Measurement of the urinary benzene metabolite trans,trans-muconic acid from benzene exposure in humans J Toxicol Environ Health 48 1996 453-477
38. Nebert D.W. Drug-metabolizing enzymes, polymorphisms and inter-individual response to environmental toxicants Clin Chem Lab Med 38 9 2000 857-861
39. Naoe T. Takeyama K. Yokozawa T. Kiyoi H. Seto M. Uike N. et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia Clin Cancer Res 6 10 2000 4091-4095
40. Nedelcheva V. Gut I. Soucek P. Tichavská B. Tynkova L. Mráz J. et al. Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression Arch Toxicol 73 1999 33-40
41. Marsh J.C. Chowdry J. Parry-Jones N. Ellis S.W. Muir K.R. Gordon-Smith E.C. et al. Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia Br J Haematol 104 2 1999 266-270
42. Ross D. Siegel D. Gibson N.W. Pacheco D. Thomas D.J. Reasor M. et al. Activation and deactivation of quinones catalyzed by DT-diaphorase: evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma Free Radic Res Commun 8 4-6 1990 373-381
43. Traver R.D. Siegel D. Beall H.D. Phillips R.M. Gibson N.W. Franklin W.A. et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase) Br J Cancer 75 1997 69-75
44. 609C→T mutation and rapid fractional excretion of chlorzoxazone Cancer Res 57 1997 2839-2842
45. Kelsey K.T. Ross D. Traver R.D. Christiani D.C. Zuo Z.-F. Spitz M.R. et al. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy Br J Cancer 76 1997 852-854
46. 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia Blood 94 1999 803-807
47. Gerarde H.W. Toxicological studies on hydrocarbons: AMA archives of industrial health 1959 403-418 American Medical Association Chicago
48. Hayden J. Comstock E. The clinical toxicology of solvent abuse Clin Toxicol 9 1976 169-181
49. Duarte-Davidson R. Courage C. Rushton L. Levy L. Benzene in the environment: an assessment of the potential risks to the health of the population Occup Environ Med 58 1 2001 2-13
50. Santesson C.G. Chronic poisoning with coal tar benzene: four deaths. Clinical and pathological-anatomical observations of several colleagues and illustrating animal experiments Arch Hyg 31 1897 336-376
51. Selling L. Benzol as a leucotoxin: studies on the degeneration and regeneration of the blood and haematopoietic organs John Hopkins Hospital Reports 17 1916 83-142
52. Irons R.D. Leukemogenesis as a toxic response In: Sipes I.G. McQueen C.A. Gandolfi A.J. Bloom J.C. (Eds.) Comprehensive toxicology 1997 175-199 Elsevier Science Ltd. New York
53. Cronkite E.P. Drew R.T. Inoue T. Bullis J.E. Benzene hematotoxicity and leukemogenesis Am J Ind Med 7 1985 447-456
54. Cronkite E.P. Inoue T. Carsten A.L. Miller M.E. Bullis J.E. Drew R.T. Effects of benzene inhalation on murine pluripotent stem cells J Toxicol Environ Health 9 1982 411-421
55. Snyder C.A. Goldstein B.D. Sellakumar A.R. Wolman S.R. Bromberg I. Erlichman M.N. et al. Hematotoxicity of inhaled benzene to Sprague-Dawley rats and AKR mice at 300 ppm J Toxicol Environ Health 4 1978 605-618
56. Bio/dynamics Inc Goldstein B.D. Twelve-week inhalation toxicity study of benzene on seven species of animals 1979 API Medical Research Publishers Washington, DC
57. Green J.D. Snyder C.A. LoBue J. Goldstein B.D. Albert R.E. Acute and chronic dose/response effect of benzene inhalation on the peripheral blood, bone marrow, and spleen cells of CD-1 male mice Toxicol Appl Pharmacol 59 1981 204-214
58. Ward E. Hornung R. Morris J. Rinsky R. Wild D. Halperin W. et al. Risk of low red or white blood cell count related to estimated benzene exposure in a rubberworker cohort (1940-1975) Am J Ind Med 29 1996 247-257
59. Kipen H.M. Cody R.P. Crump K.S. Allen B.C. Goldstein B.D. Hematologic effects of benzene: a thirty-five year longitudinal study of rubber workers Toxicol Ind Health 4 4 1988 411-430
60. Rothman N. Li G.-L. Dosemeci M. Bechtold W.E. Marti G.E. Wang Y.-Z. et al. Hematotoxicity among Chinese workers heavily exposed to benzene Am J Ind Med 29 1996 236-246
61. Michiels J.J. Preface Semin Thromb Hemost 23 1997 333-341
62. Irons R.D. Moore B.J. Effect of short term benzene administration on circulating lymphocyte subpopulations in the rabbit: evidence of a selective b-lymphocyte sensitivity Res Commun Chem Pathol Pharmacol 27 1 1980 147-155
63. Pyatt D.W. Yang Y. Stillman W. Irons R.D. Hydroquinone inhibits PMA-induced activation of NF-kB in primary human CD19 + B lymphocytes Cell Biol Toxicol 16 2000 41-51
64. Environmental Protection Agency Benzene: IRIS (Integrated Risk Information System) Available at: http://toxnet.nlm.gov/cgi-bin/ sis/search/ Accessed December 15, 2003
65. Hamilton A. The growing menace of benzene (benzol) poisoning in American industry JAMA 78 1922 627 638
66. Greenburg L. Mayers M.R. Goldwater L.J. Smith A.R. Benzene (benzol) poisoning in the rotogravure printing industry in New York City J Ind Hyg Toxicol 21 8 1939 395-420
67. Aksoy M. Leukemia in workers due to occupational exposure to benzene New Istanbul Contrib Clin Sci 12 l 1977 3-14
68. Aksoy M. Dinçol K. Akgün T. Erdem S. Dinçol G. Haematological effects of chronic benzene poisoning in 217 workers Br J Ind Med 28 1971 296-302
69. Aksoy M. Erdem S. Dinçol G. Leukemia in shoe-workers exposed chronically to benzene Blood 44 6 1974 837-841
70. Forni A. Vigliani E.C. Chemical leukemogenesis in man Semin Hematol 7 2 1974 211-223
71. Forni A.M. Cappellini A. Pacifico E. Vigliani E.C. Chromosome changes and their evolution in subjects with past exposure to benzene Arch Environ Health 23 1971 385-391
72. Vigliani E.C. Forni A. Benzene and leukemia Environ Res 11 1976 122-127
73. Erf L.A. Rhoads C.P. The hematological effects of benzene (benzol) poisoning J Ind Hyg Toxicol 21 1939 421-435
74. Goldwater L.J. Disturbances in the blood following exposure to benzol J Lab Clin Med 26 1941 957-973
75. Pisciotta A.V. Drug-induced leukopenia and aplastic anemia Clin Pharmacol Ther 12 1971 13-43
76. Young N.S. Abkowitz J.L. Luzzatto L. New insights into the pathophysiology of acquired cytopenias Hematology 2000 18-38
77. Young N.S. Acquired aplastic anemia Ann Intern Med 136 7 2002 534-546
78. Jandl J.H. Blood: textbook of hematology 1997 Little, Brown & Company Boston
79. Rowley J.D. Golomb H.M. Vardiman J. Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin's disease and non-Hodgkin lymphomas Blood 50 1977 759-770
80. Pedersen-Bjergaard J. Nissen N.I. Sorensen H.M. Hou-Jensen K. Larsen M.S. Ernst P. et al. Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (dihydroxybusulfan) Cancer 45 1980 19-29
81. Pedersen-Bjergaard J. Philip P. Mortensen B.T. Ersboll J. Jensen G. Panduro J. et al. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases: clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing Blood 57 4 1981 712-723
82. Le Noire C. Sur un cas de purapura attribue a l'intoxication par le benzene Bull Mem Soc Med Hop Paris 14 1897 1251-1260
83. Delore P. Borgomano: leucémie aiguë au cours de l'intoxication benzénique J Med Lyon 9 1928 227-233
84. Lignac G.O.E. Leukemia in humans and white mice due to benzene Krankheitzforschung 9 1932 403-453
85. Vigliani E.C. Saita G. Benzene and leukemia N Engl J Med 271 1964 872-876
86. Aksoy M. Dincol K. Erdem S. Dincol G. Acute leukemia due to chronic exposure to benzene Am J Med 52 1972 160-166
87. LaFleur H. Myelogenous leukemia-treatment by benzol and x-ray Can Med Assoc J 10 1920 996-1007
88. Ott M.G. Townsend J.C. Fishback W.A. Langner R.A. Mortality among individuals occupationally exposed to benzene Arch Environ Health January/February 1978 3-10
89. Infante P.F. Rinsky R.A. Wagoner J.K. Young R.J. Leukaemia in benzene workers Lancet 2 1977 76-78
90. Rinsky R.A. Young R.J. Smith A.B. Leukemia in benzene workers Am J Ind Med 2 1981 217-245
91. Rinsky R.A. Smith A.B. Hornung R.W. Filloon T.G. Young R.J. Okun A.H. et al. Benzene and leukemia: an epidemiologic risk assessment N Engl J Med 316 17 1987 1044-1050
92. Yin S.-N. Li G.-L. Tain F.-D. Fu Z.-I. Jin C. Chen Y.-J. et al. Leukaemia in benzene workers: a retrospective cohort study Br J Ind Med 44 1987 124-128
93. Yin S.-N. Li G.-L. Tain F.-D. Fu Z.-I. Jin C. Chin Y.-J. et al. A retrospective cohort study of leukemia and other cancers in benzene workers Environ Health Perspect 82 1989 207-213
94. Yin S.-N. Hayes R.B. Linet M.S. Li G.-L. Dosemeci M. Travis L.B. et al. A cohort study of cancer among benzene-exposed workers in China: overall results Am J Ind Med 29 1996 227-235
95. Decouflé P. Blattner W.A. Blair A. Mortality among chemical workers exposed to benzene and other agents Environ Res 30 1983 16-25
96. Bond G.G. McLaren E.A. Baldwin C.L. Cook R.R. An update of mortality among chemical workers exposed to benzene Br J Ind Med 43 1986 685-691
97. Bond G.G. McLaren E.A. Cartmill J.B. Wymer K.T. Sobel W. Lipps T.E. et al. Cause-specific mortality among male chemical workers Am J Ind Med 12 4 1987 353-383
98. Ott M.G. Teta M.J. Greenburg H.L. Lymphatic and hematopoietic tissue cancer in a chemical manufacturing environment Am J Ind Med 16 1989 631-643
99. Paci E. Buiatti E. Costantini A.S. Miligi L. Pucci N. Scarpelli A. et al. Aplastic anemia, leukemia and other cancer mortality in a cohort of shoe workers exposed to benzene Scand J Work Environ Health 15 1989 313-318
100. Wong O. An industry wide mortality study of chemical workers occupationally exposed to benzene. II. Dose response analyses Br J Ind Med 44 1987 382-395
101. Crump K.S. Allen B.C. Quantitative estimates of risk of leukemia from occupational exposure to benzene. OSHA Docket H-059b, Exhibit 152 (Appendix B) 1984 OSHA Washington, DC
102. Infante P.F. White M.C. Benzene: epidemiologic observations of leukemia by cell type and adverse health effects associated with low-level exposure Environ Health Perspect 52 1983 7582
103. Kipen H.M. Cody R.P. Goldstein B.D. Use of longitudinal analysis of peripheral blood counts to validate historical reconstructions of benzene exposure Environ Health Perspect 82 1989 199-206
104. Paxton M.B. Chinchilli V.M. Brett S.M. Rodricks J.V. Leukemia risk associated with benzene exposure in the pliofilm cohort: II. Risk estimates Risk Anal 14 1994 147-154
105. Paxton M.B. Chinchilli V.M. Brett S.M. Rodricks J.V. Leukemia risk associated with benzene exposure in the pliofilm cohort: I. Mortality update and exposure distribution Risk Anal 14 1994 147-154
106. Silver S.R. Rinsky R.A. Cooper S.P. Hornung R.W. Lai D. Effect of follow-up time on risk estimates: a longitudinal examination of the relative risks of leukemia and multiple myeloma in a rubber hydrochloride cohort Am J Ind Med 42 2002 481-489
107. Rinsky R.A. Hornung R.W. Silver S.R. Tseng C.Y. Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment Am J Ind Med 4 2002 474-480
108. Paustenbach D.J. Price P.S. Ollison W. Blank C. Jernigan J.D. Bass R.D. et al. Reevaluation of benzene exposure for the pliofilm (rubberworker) cohort (1936-1976) J Toxicol Environ Health 36 1992 177-231
109. Schnatter A.R. Nicolich M.J. Bird M.G. Determination of leukemogenic benzene exposure concentrations: refined analysis of the pliofilm cohort Risk Anal 16 1996 833-840
110. Williams P.R.D. Paustenbach D.J. Reconstruction of benzene exposure for the pliofilm cohort (1936-1976) using Monte Carlo techniques J Toxicol Environ Health A 66 2003 677-781
111. White M.C. Infante P.F. Chu K.C. A quantitative estimate of leukemia mortality associated with occupational exposure to benzene Risk Anal 2 1982 195-204
112. Larson R. Myeloid leukemia after cytotoxic therapy and other hematotoxins J Toxicol Environ Health A 61 2000 381-386
113. Coltman C.A. Dahlberg S. Treatment-related leukemia N Engl J Med 322 1990 52-53
114. Park D.J. Koeffler H.P. Therapy-related myelodysplastic syndromes Semin Hematol 33 1996 256-273
115. Rowley J.D. Le Beau M.M. Cytogenetic and molecular analysis of therapy-related leukemia Ann N Y Acad Sci 567 1989 130-140
116. Leone G. Mele L. Pulsoni A. Equitani F. Pagano L. The incidence of secondary leukemias Haematologica 84 1999 937-945
117. Mallory T.B. Gall E.A. Brickley W.J. Chronic exposure to benzene (benzol). III. The pathologic results J Ind Hyg Toxicol 21 8 1939 355-377
118. Linet M.S. Yin S.N. Travis L.B. Li C.Y. Zhang Z.N. Li D.G. et al. Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China Environ Health Perspect 104 Suppl 6 1996 1353-1364
119. Snyder R. Kalf G.F. A perspective on benzene leukemogenesis Crit Rev Toxicol 24 1994 177-209
120. Bowen D.T. Oxidative stress and the myelodysplastic syndromes Leuk Res 24 2000 139-140
121. Pedersen-Bjergaard J. Andersen M.K. Christiansen D.H. Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia Blood 99 6 2002 1909-1912
122. Rushton L. Romaniuk H. A case-control study to investigate the risk of leukemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom Occup Environ Med 54 1997 152-166
123. Wong O. Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene Occup Environ Med 52 1995 380-384
124. Beaumont M. Sanz M. Carli P.M. Maloisel X. Thomas L. Fenaux P. Therapy-related acute promyelocytic leukemia J Clin Oncol 21 2003 2123-2137
125. De Renzo A. Santoro L.F.E. Notaro R. Pane F. Buonaiuto M.R. Luciano L. et al. Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II Am J Hematol 60 1999 300-304
126. Albitar M. Manshouri T. Shen Y. Liu D. Beran M. Kantarjian H.M. et al. Myelodysplastic syndrome is not merely preleukemia Blood 100 3 2002 791-798
127. Mijovic A. Mufti G.J. The myelodysplastic syndromes: towards a functional classification Blood Rev 12 1998 73-83
128. Barrett J. Saunthararajah Y. Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol 37 2000 15-29
129. Vallespi T. Imbert M. Mecucci C. Preudhomme C. Fenaux P. Diagnosis, classification, and cytogenetics of myelodysplastic syndromes Haematologica 83 3 1998 258-275
130. Pierre R.V. Preleukemic states Semin Hematol 11 1 1974 73-92
131. Block M. Jacobson L.O. Bethard W.F. Preleukemic acute human leukemia JAMA 152 11 1953 1018-1028
132. Anderson R.L. Bagby G.C. Jr Richert-Boe K. Magenis R.E. Koler R.D. Therapy-related preleukemic syndrome Cancer 47 1981 1867-1871
133. Aul C. Bowen D.T. Yoshida Y. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes Haematologica 83 1998 71-86
134. Westbrook C.A. Hsu W.T. Chyna B. Litvak D. Raza A. Horrigan S.K. Cytogenetic and molecular diagnosis of chromosome 5 deletions in myelodysplasia Br J Haematol 110 2000 847-855
135. Sawyers C.L. Molecular abnormalities in myeloid leukemias and myelodysplastic syndromes Leuk Res 22 1998 1113-1122
136. Pedersen-Bjergaard J. Timshel S. Andersen M.K. Andersen A.S. Philip P. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases Genes Chromosomes Cancer 23 4 1998 337-349
137. Andersen M.K. Johansson B. Larsen S.O. Pedersen-Bjergaard J. Chromosomal abnormalities in secondary MDS and AML: relationship to drugs and radiation with specific emphasis on the balanced rearrangements Haematologica 83 6 1998 483-488
138. Pedersen-Bjergaard J. Philip P. Chromosome characteristics of therapy-related acute non-lymphocytic leukemia and preleukemia: possible implications for pathogenesis of the disease Leuk Res 11 1987 315-318
139. Irons R.D. Stillman W.S. Colagiovanni D.B. Henry V.A. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro Proc Natl Acad Sci U S A 89 1992 3691-3695
140. Kerzic P.J. Pyatt D.W. Zheng J.H. Gross S.A. Le A. Irons R.D. Inhibition of NF-kappaB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-alpha-induced apoptosis Toxicology 187 2-3 2003 127-137
141. Hoffmann L. Moller P. Pedersen-Bjergaard J. Wagge A. Pedersen M. Hirsch F.R. Therapy-related acute promyelocytic leukemia with t(15;17)(q22;q12) following chemotherapy with drugs targeting DNA topoisomerase. II. A report of two cases and a review of the literature Ann Oncol 6 1995 781-788
142. Anderson M. Larson R. Mauritzson N. Schnittger S. Jhanwar S. Pedersen-Bjergaard J. Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop Genes Chromosomes Cancer 33 2002 395-400
143. Chen H.W. Eastmond D.A. Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects Carcinogenesis 16 1995 2301-2307
144. Fagioli F. Cuneo A. Piva N. Carli M.G. Previati R. Balboni M. et al. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents Cancer 70 1992 77-85
145. Baker R.K. Kurz E.U. Pyatt D.W. Irons R.D. Kroll D.J. Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIα Blood 98 2001 830-833
146. Verfaillie C.M. Biology of chronic myelogenous leukemia Hematol Oncol Clin North Am 12 1998 1-29
147. Verfaillie C.M. Stem cells in chronic myelogenous leukemia Hematol Oncol Clin North Am 11 1997 1079-1114
148. Corso A. Lazzarino M. Morra E. Merante S. Astori C. Bernasconi P. et al. Chronic myelogenous leukemia and exposure to ionizing radiation: a retrospective study of 443 patients Ann Hematol 70 1995 79-82
149. Vigliani E.C. Leukemia associated with benzene exposure Ann N Y Acad Sci 271 1976 143-151
150. Smith S.M. Le Beau M.M. Huo D. Karrison T. Sobecks R.M. Anastasi J. et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series Blood 102 1 2003 43-52
151. Le Beau M.M. Albain K.S. Larson R.A. Vardiman J.W. Davis E.M. Blough R.R. et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes number 5 and 7 J Clin Oncol 4 3 1986 325-345
152. American Cancer Society Clinical oncology 2001 American Cancer Society Atlanta
153. Kurec A.S. Threatte G.A. Gottlieb A.J. Smith J.R. Anderson J. Davey F.R. Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL) Br J Haematol 81 1 1992 45-51
154. Murphy G.P. Lawrence W. Lenhard R.E. (Ed.) American Cancer Society Textbook of Clinical Oncology 1995 496 American Cancer Society Atlanta (GA)
155. Andjelkovic D. Taulbee J. Mortality experience of a cohort of rubber workers, 1964-1973 J Occup Med 18 6 1976 387-394
156. Delzell E. Monson R.R. Mortality among rubber workers III. cause-specific mortality, 1940-1978 J Occup Med 23 10 1981 677-684
157. McMichael A.J. Spirtas R. Kupper L. An epidemiologic study of mortality within a cohort of rubber workers J Occup Med 16 1974 458-464
158. McMichael A.J. Spirtas R. Kupper L.L. Gamble J.F. Solvent exposure and leukemia among rubber workers: an epidemiologic study J Occup Med 17 4 1975 234-239
159. McMichael A.J. Spirtas R. Gamble J.F. Tousey P.M. Mortality among rubber workers: relationship to specific jobs J Occup Med 18 1976 178-185
160. Checkoway H. Wilcosky T.C. Wolf P.H. Tyroler H.A. An evaluation of the associations of leukemia and rubber industry solvent exposures Am J Ind Med 5 1984 239-249
161. Garfinkel L. Cancer statistics and trends: clincial oncology 1995 American Cancer Society Atlanta
162. Devesa S.S. Fears T. Non-Hodgkin's lymphoma time trends: United States and international data Cancer Res 52 1992 5432-5440
163. Anderson J.R. Armitage J.O. Weisenburger D.D. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project Ann Oncol 9 7 1998 717-720
164. Garber K. Lymphoma rate rise continues to baffle researchers J Natl Cancer Inst 93 2001 494-496
165. Baris D. Zahm S.H. Epidemiology of lymphomas Curr Opin Oncol 12 5 2000 383-394
166. Mueller N. Overview of the epidemiology of malignancy in immune deficiency J Acquir Immune Defic Syndr 21 Suppl 1 1999 S5-S10
167. Opelz G. Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 1993 1514-1516
168. Meijer C.J. Jiwa N.M. Dukers D.F. Oudejans J.J. de Bruin P.C. Walboomers J.M. et al. Epstein-Barr virus and human T-cell lymphomas Semin Cancer Biol 7 4 1996 191-196
169. Levine A.M. Lymphoma complicating immunodeficiency disorders Ann Oncol 5 1994 29-35
170. Hardell L. Axelson O. Environmental and occupational aspects on the etiology of non-Hodgkin's lymphoma Oncol Res 10 1 1998 1-5
171. Lee S.-H. Su I.-J. Chen R.-L. Lin K.-S. Lin D.-T. Chuu W.-M. A pathologic study of childhood lymphoma in Taiwan with special reference to peripheral T-cell lymphoma and the association with Epstein-Barr viral infection Cancer 68 1991 1954-1962
172. Isaacson P.G. Spencer J. Gastric lymphoma and Helicobacter pylori In: DeVita V.T. Hellman S. Rosenberg S.A. (Eds.) Important advances in oncology 1996 111-121 Lippincott-Raven Philadelphia
173. Zuckerman E. Zuckerman T. Levin A.M. Douer D. Gutekunst K. Mizokami M. et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma Ann Intern Med 127 1997 423-428
174. Cammarota G. Tursi A. Mantalto M. Papa A. Branca G. Vecchio F.M. et al. Prevention and treatment of low-grade B-cell primary gastric lymphoma aby anti-H. Pylori therapy J Clin Gastroenterol 21 1995 118-122
175. Persson B. Dahlander A.-M. Fredriksson M. Brage H.N. Ohlson C.-G. Axelson O. Malignant lymphomas and occupational exposures Br J Ind Med 46 1989 516-520
176. Scherr P.A. Hutchison G.B. Neiman R.S. Non-Hodgkin's lymphoma and occupational exposure Cancer Res 52 1992 5503s-5509s
177. O'Connor S.R. Farmer P.B. Lauder I. Benzene and non-Hodgkin's lymphoma J Pathol 189 1999 448-453
178. Hayes R.B. Yin S.N. Dosemeci M. Li G.L. Wacholder S. Travis L.B. et al. Benzene and the dose-related incidence of hematologic neoplasms in China J Natl Cancer Inst 89 1997 1065-1071
179. Nilsson R.I. Nordlinder R. Horte L.-G. Jarvholm B. Leukaemia, lymphoma, and multiple myeloma in seamen on tankers Occup Environ Med 55 1998 517-521
180. Nilsson R. Nordlinder R. Horte L. Jarvholm B. Leukemia, lymphoma and multiple myeloma is seamen on tankers Occup Environ Med 55 1998 517-522
181. Fritschi L. Siemiatycki J. Lymphoma, myeloma and occupation: results of a case-control study Int J Cancer 67 1996 498-503
182. Wong O. An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results Br J Ind Med 44 1987 365-381
183. Norseth T. Andersen A. Giltvedt J. Cancer incidence in the rubber industry in Norway Scand J Work Environ Health 9 1983 69-71
184. Schnatter A.R. Armstrong T.W. Nicolich M.J. Thompson F.S. Katz A.M. Huebner W.W. et al. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers Occup Environ Med 53 1996 773-781
185. Bakkus M.H.C. Van Riet I. De Greef C. Van Camp B. Thielemans K. The clonogenic precursor cell in multiple myeloma Leuk Lymphoma 18 1995 221-229
186. Lynch H. Sanger W. Pirrucello S. Quinn-Laquer B. Weisenberger D. Familial multiple myeloma: a family study and review of the literature J Natl Cancer Inst 93 2001 1479
187. Brown L. Linet M. Greenburg R. Silverman D. Hayes R. Swanson G. et al. Multiple myeloma and family history of cancer among blacks and whites in the US Cancer 85 1999 2385
188. Eriksson M. Hallberg B. Familial occurrence of hematologic malignancies and other diseases in multiple myeloma case-control study Cancer Causes Control 3 1992 63-67
189. Rettig M.B. Ma H.J. Vescio R.A. Pold M. Schiller G. Belson D. et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients Science 276 1997 1851-1854
190. Torres A. Giralt M. Raichs A. Coexistencia de antecedentes benzólicos crónicos y plasmocitoma múltiple: presentación de dos casos Sangre (Barc) 15 1970 275-279
191. Aksoy M. Erdem S. Dinçol G. Kutlar A. Bakioglu I. Hepyüksel T. Clinical observations showing the role of some factors in the etiology of multiple myeloma Acta Haematol 71 1984 116-120
192. Kyle R.A. Greipp P.R. Multiple myeloma: houses and spouses Cancer 51 1983 735-739
193. Goldstein B.D. Is exposure to benzene a cause of human multiple myeloma? Ann N Y Acad Sci 609 1990 225-234
194. Teitelbaum D.T. Brautbar N. Mehlman M. LaDou J. Benzene and multiple myeloma: appraisal of the scientific evidence Blood 95 2000 2995-2996
195. Wong O. Raabe G.K. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers Regul Toxicol Pharmacol 26 1997 188-199
196. Sonoda T. Nagata Y. Mori M. Ishida T. Imai K. Meta-analysis of multiple myeloma and benzene exposure J Epidemiol 11 2001 249-254
197. Bergsagel D.E. Wong O. Bergsagel P.L. Alexanian R. Anderson K. Kyle R.A. et al. Benzene and multiple myeloma: appraisal of the scientific evidence Blood 94 1999 117-1182
198. Bezabeh S. Lamm S.H. Morris C.B. Engel A. Does benzene cause multiple myeloma? An analysis of the published case-control literature Environ Health Perspect 104 1996 1393-1398